Pharmacogenomics of Statin Effects in Asthma

Investigate the association of the HLA-G polymorphism, rs1063320, directly with asthma susceptibility and in a pharmacogenetic context as an effect modifier of statin effects on asthma related phenotypes, including exacerbations and lung function using a population based cohort of asthmatics with and without statin use.

Owner Phenotyping Groups: 
View Phenotyping Groups: 

Statins and MACE

Phenotype Description:  Patients on statins for primary prevention who develop an AMI or 1st AMI. 

Below are algorithms used to identify AMI and 1st AMI cohort at BioVU. If you have questions regarding any of the information presented on this page, you may contact either:

Wei-Qi Wei at

Joshua Denny at



Owner Phenotyping Groups: 
View Phenotyping Groups: